Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Payer Franz |

Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen

Klein, GE; Niederkorn, K; Gattringer, T; Fuchs, S; Enzinger, C; Payer, F; Urbanic-Purkart, T Graz Neurology Symposium - Historical development, present status and future aspects of diagnosis and treatment.
MIND & BRAIN - 59th International Neuropsychiatric Congress; May 30 - June 02, 2019; Pula, CROATIA. 2019. [Oral Communication]
FullText

 

Purkart, TU; Payer, F CAN F-DOPA PET DIFFERENTIATE GLIOMA-RECURRENCE FROM TREATMENT-RELATED CHANGES?
NEURO-ONCOLOGY. 2017; 19: 145-145. [Poster]
Web of Science FullText

 

Kneihsl, M; Enzinger, C; Wünsch, G; Khalil, M; Culea, V; Urbanic-Purkart, T; Payer, F; Niederkorn, K; Fazekas, F; Gattringer, T Poor short-term outcome in patients with ischemic stroke and active cancer
19. Jahrestagung der Österreichischen Schlaganfall-Gesellschaft; JAN, 21-23, 2016; Krems, AUSTRIA. 2016. [Oral Communication]

 

Oberndorfer, S; Marosi, C; Payer, F; Nowosielski, M; Floria, C; Hager, A; Stultschnig, M; Surbock, B; Pichler, J; Wohrer, A ABTR-SANO REAL-WORLD PATTERN OF CARE STUDY ON GLIOBLASTOMA IN THE AUSTRIAN POPULATION
NEURO-ONCOLOGY. .. 2016; 18: 21-21.-12th Meeting of the European-Association-of-Neuro-Oncology; OCT 12-16, 2016; GERMANY. [Poster]
Web of Science

 

Urbanic Purkart, T; Asslaber, M; Holl, E; Seifert- Held, T; Payer, F. Tumoröse Läsion des Mesenzephalon.
Neuroonko-Update 2016 Highlights aus der Neuroonkologie 2015; JAN 29, 2016; Salzburg, AUSTRIA. 2016. [Oral Communication]

 

Urbanic Purkart T, Holl E, Asslaber M, Seifert-Held T, Payer F Germinoma mimicking lesion of inflammatory etiology on MRI.
13. Jahrestagung der Österreichischen Gesellschaft für Neurologie; MAR 16-18, 2016; Innsbruck. 2016. [Poster]

 

Gattringer, T; Kneihsl, M; Enzinger, C; Wünsch, G; Khalil, M; Uranic-Purkart, T; Payer, F; Niederkorn, K; Fazekas, F Poor short-term outcome in patients with ischemic stroke and active cancer.
Special Issue: Abstracts of the 1st Congress of the European Academy of Neurology, Berlin, Germany, June 2015. European Journal of Neurology.. 2015; 228-228.-First congress of the European Academy of Neurology; June 20-23, 2015; Berlin, GERMANY. [Poster]
FullText

 

Gattringer, T; Kneihsl, M; Enzinger, C; Wunsch, G; Khalil, M; Urbanic-Purkart, T; Payer, F; Niederkorn, K; Fazekas, F Poor short-term outcome in patients with ischemic stroke and active cancer
EUR J NEUROL. 2015; 22: 228-228.-1st Congress of the European-Academy-of-Neurology; JUN, 2015; Berlin, GERMANY. [Poster]
Web of Science

 

Jehna, M; Becker, J; Zaar, K; Campe, G; Linortner, P; Reishofer, G; Payer, F; Synowitz, M; Fazekas, F; Enzinger, D; Deutschmann, H Sprachassoziierte strukturelle Konnektivität bei HirntumorpatientInnen
23. Jahrestagung der Österreichischen Gesellschaft für Neuroradiologie (ÖGNR); NOV 19-21, 2015; Klagenfurt, AUSTRIA. 2015. [Oral Communication]

 

Kneihsl, M; Enzinger, C; Wünsch, G; Khalil, M; Urbanic-Purkart, T; Payer, F; Niederkorn, K; Fazekas, F; Gattringer, T Koinzidenz von ischämischem Schlaganfall und maligner Grunderkrankung
12. Jahrestagung der Österreichischen Gesellschaft für Neurologie; MAR 25-27, 2015; Graz, AUSTRIA. 2015. [Poster]

 

Urbanic Purkart, T; Haybaeck, J; Kögl-Wallner, M; Seifert-Held, T; Payer, F; Fazekas, F Amyloid-beta assoziierte ZNS-Vaskulitis- eine ungewöhnliche Ursache für Enzephalopathie.
12. Jahrestagung der Österreichischen Gesellschaft für Neurologie; MAR 25-27, 2015; Graz, AUSTRIA. 2015. [Poster]

 

Urbanic Purkart, T; Payer, F Raumforderung im Bereich des Mesencephalon – Differentialdiagnostische Überlegungen
Neuroonko-Update 2015 ; 23.1.2015; Salzburg. 2015. [Oral Communication]

 

Urbanic Purkart T; Payer, F; Bohlsen, D; Fazekas, F THE IMPACT OF MRI PERFUSION IMAGING IN THE DIFFERENTIATION OF PROGRESSION AND PSEUDOPROGRESSION IN PATIENTS WITH GLIOBLASTOMA
Abstracts from the 20th Annual Scientific Meeting of the Society for Neuro-Oncology . 2015; -20th Annual Scientific Meeting of the Society for Neuro-Oncology Neuro; NOV 19-22, 2015; San Antonio, Texas, USA. [Oral Communication]
FullText

 

Hoffermann, M; Bruckmann, L; Ali, KM; Asslaber, M; Payer, F; von Campe, G SPECIFIC TREATMENT CONSIDERATIONS AND OUTCOME DATA IN ELDERLY GLIOMA PATIENTS - A SINGLE CENTER EXPERIENCE
NEURO-ONCOLOGY. . 2013; 15 (Suppl. 3): 220-220.-4th Quadrennial Meeting of the World-Federation-of-Neuro-Oncology (WFNO) held in conjunction with the 18th Annual Meeting of the Society-for-Neuro-Oncology (SNO); NOV 21-24, 2013; San Francisco, CA. [Poster]
Web of Science

 

Jehna, M; von Campe, G; Hoffermann, M; Bruckmann, L; Reishofer, G; Payer, F; Enzinger, C; Ebner, F Reorganization of cerebral language-associated areas in a 65-year-old female with anaplastic astrocytoma as evidenced by fMRI and DCS
Behavioural Neurology. 2013; 27(3):-4th Meeting of the Federation of European Societies of Neuropsychology (FESN) / 28th Meeting of the German Society of Neuropsychology (GNP); SEP 12-14, 2013; Berlin, GERMANY. (ISBN: 0953-4180 ) [Poster]

 

Jehna, M; von Campe, G; Hoffermann, M; Bruckmann, L; Reishofer, G; Payer, F; Enzinger, C; Ebner, F The value of preoperative fMRI in drawing attention to possible unexpected language area representations in a patient with anaplastic astrocytoma.
J Neurol Sci. 2013; 333 (Suppl. 1): e609-e610.-XXI World Congress of Neurology; SEP 21-26, 2013; Vienna, AUSTRIA. [Poster]

 

Hoffermann, M; Bruckmann, L; Asslaber, M; Payer, F; von Campe, G Prognostische und therapeutische Implikationen bei über 65-jährigen Gliompatienten.
48. Jahrestagung der Österreichischen Gesellschaft für Neurochirurgie "Geriatrische Probleme in der Neurochirurgie. Indikationen & Therapiemodalitäten"; OCT 4-6, 2012; Graz, AUSTRIA. 2012. [Oral Communication]

 

Groll, M; Quehenberger, F; Partl, R; Payer, F; Kapp, KS; Langsenlehner, T Höhergradige Gliome: Überlebensraten und prognostische Faktoren in interdisziplinären Behandlungskonzepten.
STRAHLENTHER ONKOL. 2011; 187(1):82--27. Jahrestagung der Österreichischen Gesellschaft für Radioonkologie, Radiobiologie und Medizinische Radiophysik (ÖGRO); NOV 19-20, 2010; Krems, AUSTRIA. [Poster]
Web of Science

 

Batchelor, T; Mulholland, P; Neyns, B; Nabors, LB; Campone, M; Wick, A; Mason, W; Mikkelsen, T; Phuphanich, S; Ashby, LS; DeGroot, JF; Gattamancni, HR; Cher, LM; Rosenthal, MA; Payer, F; Xu, J; Liu, Q; van den Bent, M THE EFFICACY OF CEDIRANIB AS MONOTHERAPY AND IN COMBINATION WITH LOMUSTINE COMPARED TO LOMUSTINE ALONE IN PATIENTS WITH RECURRENT GLIOBLASTOMA: A PHASE III RANDOMIZED STUDY
NEURO-ONCOLOGY. 2010; 12: 75-75. [Poster]
Web of Science

 

Szkandera, J; Ploner, F; Bauernhofer, T; Kasparek, AK; Payer, F; Balic, M; Knechtel, G; Gerger, A; Galle; Samonigg, H; Hofmann, g; Paraneoplastic limbic encephalitis in a patient with extragonadal chorioncarcinoma - the significance of onconeural antibodies: a case report
MEMO Suppl 01/10; 2010; 20-21.-Frühjahrstagung 2010 der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 8-10; Bregenz, AUSTRIA . [Poster]

 

Payer, F Hirntumore und andere Raumforderungen.
Facharztausbildungsseminar der Österreichischen Gesellschaft für Neurologie (ÖGN); NOV 5-7, 2009; Graz, AUSTRIA. 2009. [Oral Communication]

 

Payer, F Schlaganfälle in der Onkologie.
Fortbildungstag "Neurologie und Onkologie" der ARGE Neuroonkologie der Österreichischen Gesellschaft für Neurologie (ÖGN); OCT 16, 2009; Salzburg, AUSTRIA. 2009. [Oral Communication]

 

Payer, F Therapie primärer Tumore
6. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); FEB 6-9, 2008; Innsbruck, AUSTRIA. 2008. [Oral Communication]

 

Payer, F; Wurm, W; Weiss, S; Zechner, B; Fazekas, F Usefulness of F-DOPA PET in the differentiation of recurrent glioma from radiation necrosis.
Neuro-Oncology2008; 10(6):1101-1101.-8th meeting of the European Association for Neuro-Oncology (EANO); SEP 12-14, 2008; Barcelona, SPAIN. [Oral Communication]
Web of Science

 

Reishofer, G; Fazekas, F; Keeling, S; Enzinger, C; Payer, F; Simbrunner, J; Stollberger, R Minimizing Macrovessel Signal in Cerebral Perfusion Imaging Using Independent Component Analysis
11. Jahrestagung der Österreichischen Gesellschaft für Schlaganfall-Forschung; JAN 25-26, 2008; Linz. 2008. [Oral Communication]

 

Wurm, W; Payer, F; Weiss, S; Zechner, B; Fazekas, F Value of F-DOPA PET for the Differentiation of Recurrent HIgh-Grade Glioma and Radio-/Chemonecrosis
6. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); FEB 6-9, 2008; Innsbruck, AUSTRIA. 2008. [Poster]

 

Holl, A; Feichtinger, M; Payer, F; Fazekas, F; Ott, E Extensive transient imaging abnormalities in patients with gliomas following seizures. An important differential diagnosis
EPILEPSIA. 2007; 48: 61-61. [Poster]
Web of Science

 

Mayer, R; Payer, F; Quehenberger, F; Weiss, S; Eder, T; Fazekas, F Combined radiochemotherapy and prolonged adjuvant chemotherapy with temozolamide in patients with glioblastoma multiforme.
-17th International Congress on Anti-Cancer Treatment; JAN 30-FEB 2, 2006; Paris, FRANCE. [Poster]

 

Payer, F; Mayer, R; Weiss, S; Quehenberger, F; Eder, T; Fazekas, F Chemoradiation and prolonged adjuvant temozolomide in high-grade glioma: Analysis of outcome and side effects
NEURO-ONCOLOGY. 2006; 8(4):355-355. [Oral Communication]
Web of Science

 

Payer, F; Mayer, R; Weiss, S; Scarpatetti, M; Fazekas F Chemoradiation and prolonged adjuvant Temozolomide in high grad glioma: Analysis of outcome and side effects.
Abstract2006; -Seventh Congress of the European Association for Neuro-Oncology (EANO); 14.09-17.09 2006; Vienna. [Oral Communication]

 

Seewann, A; Payer, F Meningeosis carcinomatosa bei CUP. Kombinationstherapie von intrathekalem Depot Cytarabin und oralem Temozolamid. Ein Fallbericht.
3. Jahrestagung der oesterreichischen Gesellschaft fuer Neurologie (OEGN); April 21-23, 2005; Vienna, AUSTRIA. 2005. [Poster]

 

Scarpatetti, M; Mokry, M; Payer, F; Kleinert, R Unsuspected and rare lesions of the sellar region
ACTA NEUROPATHOL 2002 104: 567-567.
Web of Science

 

© Med Uni Graz Impressum